The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma

by Le-gao Chen, Le-gao Chen, Le-gao Chen, Ying Cui, Wei-qin Lu, Hao Wu, Jin-song Jiang, Ke-feng Ding, Ke-feng Ding
Published 2022-12-01

OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis

by Yue Liu, Xiang-Xing Kong, Jin-Jie He, Yan-Bo Xu, Jian-Kun Zhang, Lu-Yang Zou, Ke-Feng Ding, Dong Xu
Published 2022-04-01

Oxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancer.

by Jun Li, Yue Liu, Jian-Wei Wang, Yang Gao, Ye-Ting Hu, Jin-Jie He, Xiu-Yan Yu, Han-Guang Hu, Ying Yuan, Su-Zhan Zhang, Ke-Feng Ding
Published 2014-01-01

Circulation immune cell landscape in canonical pathogenesis of colorectal adenocarcinoma by CyTOF analysis

by Xiang-Xing Kong, Jia-Sheng Xu, Ye-Ting Hu, Yu-Rong Jiao, Sheng Chen, Cheng-Xuan Yu, Si-Qi Dai, Zong-Bao Gao, Xu-Ran Hao, Jun Li, Ke-Feng Ding
Published 2024-03-01

The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract—A Single-Center Retrospective Study

by Xiang-Xing Kong, Xiang-Xing Kong, Xin-Lin Li, Xin-Lin Li, Xin-Lin Li, Yu Tian, Qian-Cheng Ye, Xiao-Ming Xu, Xiao-Ming Xu, Yue Liu, Yue Liu, Qi Yang, Qi Yang, Li-Na Zhang, Li-Na Zhang, Yan-Xia Mei, Yan-Xia Mei, Ji-Hang Wen, Ji-Hang Wen, Qian Xiao, Qian Xiao, Jing-Song Li, Jing-Song Li, Ke-Feng Ding, Ke-Feng Ding, Jun Li, Jun Li
Published 2021-04-01

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer

by Gong Chen, Junjie Peng, Qian Xiao, Hao-Xiang Wu, Xiaojun Wu, Fulong Wang, Liren Li, Peirong Ding, Qi Zhao, Yaqi Li, Da Wang, Yang Shao, Hua Bao, Zhizhong Pan, Ke-Feng Ding, Sanjun Cai, Feng Wang, Rui-Hua Xu
Published 2021-05-01

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial

by Rui-Hua Xu, Lin Shen, Ke-Ming Wang, Gang Wu, Chun-Mei Shi, Ke-Feng Ding, Li-Zhu Lin, Jin-Wan Wang, Jian-Ping Xiong, Chang-Ping Wu, Jin Li, Yun-Peng Liu, Dong Wang, Yi Ba, Jue-Ping Feng, Yu-Xian Bai, Jing-Wang Bi, Li-Wen Ma, Jian Lei, Qing Yang, Hao Yu
Published 2017-12-01

Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study

by Jun Li, Xiang-Xing Kong, Jiao-Jiao Zhou, Yong-Mao Song, Xue-Feng Huang, Gen-Hai Li, Xiao-Jiang Ying, Xiao-Yu Dai, Min Lu, Kai Jiang, Dong-Liang Fu, Xin-Lin Li, Jin-Jie He, Jian-Wei Wang, Li-Feng Sun, Dong Xu, Jing-Yan Xu, Min Chen, Yu Tian, Jing-Song Li, Min Yan, Ying Yuan, Ke-Feng Ding
Published 2019-10-01

Clinical evaluation of a multitarget fecal immunochemical test‐sDNA test for colorectal cancer screening in a high‐risk population: a prospective, multicenter clinical study

by Ye‐Ting Hu, Xiao‐Feng Chen, Chun‐Bao Zhai, Xiao‐Tian Yu, Gang Liu, Zhi‐Guo Xiong, Zi‐Qiang Wang, San‐Jun Cai, Wen‐Cai Li, Xiang‐Xing Kong, Qian Xiao, Cai‐Hua Wang, Zhi‐Hua Tao, Li‐Yun Niu, Jian‐Long Men, Qing Wang, Shao‐Zhong Wei, Jun‐Jie Hu, Ting‐Han Yang, Jun‐Jie Peng, Guo‐Zhong Jiang, Ning Lv, Yi‐You Chen, Shu Zheng, Yan‐Hong Gu, Ke‐Feng Ding
Published 2023-08-01